Reckitt/Mead Johnson Nutrition is recalling the products due to a chance of contamination with Cronobacter sakazakii in products sampled outside of America
A product image of Nutramigen hypoallergenic infant formula powder. (Credit: Business Wire)
Nutrition products maker Reckitt/Mead Johnson Nutrition (MJN) has voluntarily recalled select batches of Nutramigen hypoallergenic infant formula powder because of possible health risks from the US market.
Nutramigen Powder is a speciality infant formula for the dietary management of Cows Milk Allergy (CMA), available in 12.6 and 19.8 oz cans.
Reckitt/Mead Johnson is recalling the products due to a chance of contamination with Cronobacter sakazakii in products sampled outside America.
MJN said that the suspicious products underwent extensive testing and tested negative for the bacteria.
The 12.6- and 19.8-ounce containers of Nutramigen, which were mainly distributed in June, July, and August 2023, were produced in June 2023.
The company believes that most, if not all, of the products recalled in the US have been consumed due to the restricted availability of the remaining supply of this infant formula.
As of now, there have been no reports of diseases or adverse events. The items were sold at retail establishments around the country.
The recalled product batches include ZL3FHG, ZL3FMH, ZL3FPE, ZL3FQD, ZL3FRW and ZL3FXJ.
The batch code located on the can’s bottom can be used to identify the affected batches, the nutrition products maker said.
Furthermore, these products have a UPC Code of 300871239418 or 300871239456 and Use by Date of 1 Jan 2025.
During this finished product campaign, Reckitt/Mead Johnson Nutrition produced extra goods that were shipped outside of the US. The company will soon contact the regulatory bodies in each of those nations.
Reckitt/MJN said that the customers who purchased Nutramigen should examine the can’s bottom to see if the batch number is impacted.
The products having the above-mentioned batch codes should be disposed of or get in touch with the company to receive a full refund, the firm said.